10-Q: Nature's Sunshine Q1 2026 Financial Results

Nature's Sunshine Products reported an 8.5% increase in Q1 2026 net sales to $122.9 million, driven by growth across all geographic segments.

Summary

• Net sales reached $122.9 million, an 8.5% increase compared to $113.2 million in Q1 2025.
• Operating income rose to $9.5 million from $6.1 million in the prior year period.
• Net income attributable to common shareholders was $5.1 million, or $0.29 per diluted share.
• Asia segment sales grew 7.3%, Europe 9.5%, North America 9.4%, and Latin America/Other 9.7%.
• The company fully acquired its two China joint ventures in December 2025, now owning 100%.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a solid performance, characterized by strong top-line growth and margin expansion, though tempered by regulatory uncertainty and negative operating cash flow.

Positives

• Consolidated net sales growth of 8.5% year-over-year.
• Operating income margin expansion to 7.8% from 5.4% in Q1 2025.
• Cost of sales as a percentage of net sales improved to 26.8% from 27.9%.
• Strong performance in North America and China markets.
• Maintained a healthy cash position of $87.6 million.

Negatives

• Taiwan market net sales declined by 16.1% due to slower consumer acquisition.
• Operating cash flow was negative $1.8 million for the quarter, compared to positive $2.6 million in Q1 2025.
• Foreign exchange losses of $1.4 million negatively impacted the bottom line.
• Effective tax rate increased to 37.2% from 31.3%.

Risks

• Ongoing geopolitical conflict in Eastern Europe impacting regional operations.
• Potential fines or penalties from pending voluntary self-disclosures to BIS and OFAC regarding trade controls.
• Exposure to foreign currency exchange rate fluctuations.
• Reliance on independent consultants and potential regulatory challenges to the direct selling business model.
• Supply chain disruptions and potential tariff-related cost increases.

Future Outlook

The company expects foreign markets with non-U.S. Dollar functional currencies to remain a significant portion of sales and expenses. Management continues to monitor the Eastern European conflict and potential tariff impacts on raw material costs for the remainder of 2026.

Management Comments

• Management noted that the increase in net sales was primarily related to product sales increases in each of the operating segments.
• The company highlighted that the decrease in cost of sales percentage was primarily due to cost savings initiatives and market mix.
• Management stated that they are unable to predict the outcome or timing of the resolution regarding the voluntary self-disclosures to BIS and OFAC.

Industry Context

StockSavvy.ai notes that Nature's Sunshine is navigating a challenging global environment by leveraging its direct-selling model, though it faces headwinds similar to other multi-level marketing firms regarding regulatory scrutiny and international market volatility.

Comparison to Industry Standards

• Performance in the health and wellness direct-selling sector remains sensitive to consumer discretionary spending.
• The company's shift toward 100% ownership of its China operations aligns with broader industry trends of consolidating control in key growth markets.
• The 8.5% sales growth outperforms many legacy direct-selling peers currently struggling with consultant retention.

Legal Proceedings

• The company is involved in an internal investigation and voluntary self-disclosures to BIS and OFAC regarding potential trade control violations.

Stakeholder Impact

• Shareholders benefit from continued share repurchases and improved profitability.
• Independent consultants are supported by ongoing training and incentive programs.
• Regulatory bodies are engaged through the company's voluntary self-disclosure process.

Next Steps

• Continued monitoring of the OFAC voluntary self-disclosure process.
• Ongoing evaluation of the impact of the Eastern European conflict on regional operations.
• Execution of the remaining $16.9 million share repurchase authorization.

Key Dates

Recommendation

The company demonstrates strong operational momentum and successful market expansion, justifying a buy rating despite the regulatory overhang, which management believes is not material.

Keywords

Nature's Sunshine, Nutritional Supplements, Direct Selling, Health and Wellness, NATR, Q1 2026 Earnings